[ad_1] GOTHENBURG, Sweden, July 18, 2024 /PRNewswire/ — Q2 2024Net sales: SEK 25,606 million (27,123) Organic growth: −6.6% (7.9%), driven by lower market demand across regions and industries, except for aerospace and railway showing continuous growth.Adjusted operating profit: […]
CLIMATE CHANGE
Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update
[ad_1] LUND, Sweden, July 18, 2024 /PRNewswire/ — Hansa Biopharma today announced its first half and second quarter 2024 financial results and business update. Søren Tulstrup, President and CEO, Hansa Biopharma said: “For the third […]
HUSQVARNA GROUP: INTERIM REPORT JANUARY
[ad_1] STOCKHOLM, July 18, 2024 /PRNewswire/ — Solid cash flow in a quarter affected by weak market conditions Second quarter 2024 Net sales decreased by 9% to SEK 15,430m (16,976). Changes in exchange rates impacted […]
Renalys Pharma announces first patient dosed in registrational Phase III clinical trial of sparsentan for IgA nephropathy in Japan
[ad_1] TOKYO, July 18, 2024 /PRNewswire/ — Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; “Renalys Pharma”) announced today that the first person was dosed in its registrational Phase III clinical trial of sparsentan for the treatment of […]
BSI receives ISO 37001 certification from Speeki Europe
[ad_1] PARIS, July 18, 2024 /PRNewswire/ — Speeki Europe, a leading certification body specialising in ethical and compliance certifications, has certified the British Standards Institution (BSI) for ISO 37001. ISO 37001 stands out as a […]
